Form D/A — Bioaxia Life Sciences Fund LP
0002085914-26-000002 · filed Oct 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Reported offering amount
- —
- Reported amount sold
- $3,260,000
- Minimum investment
- $500,000
- Investors
- 6
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Bioaxia Life Sciences Fund LP
- CIK
- 2085914
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 455 10TH AVENUE
NEW YORK, NY 10018 - Phone
- 617-999-5008
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
n/a Bioaxia Life Sciences Fund GP LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
n/a Bioaxia LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Douglas Eby · Executive OfficerNew York, NY Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗